
### [MONDO:0020199](http://purl.obolibrary.org/obo/MONDO_0020199)
**Label:** conjunctival vascular anomaly

**Subclasses:** [MONDO:0013278](http://purl.obolibrary.org/obo/MONDO_0013278) (lymphedema, hereditary, 1C), [MONDO:0019313](http://purl.obolibrary.org/obo/MONDO_0019313) (hereditary lymphedema), [MONDO:0010880](http://purl.obolibrary.org/obo/MONDO_0010880) (telangiectasia, hereditary hemorrhagic, type 2), [MONDO:0007919](http://purl.obolibrary.org/obo/MONDO_0007919) (lymphedema, hereditary, 1A), [MONDO:0008840](http://purl.obolibrary.org/obo/MONDO_0008840) (ataxia telangiectasia), [MONDO:0020200](http://purl.obolibrary.org/obo/MONDO_0020200) (conjunctival hemangioma or hemolymphangioma), [MONDO:0020201](http://purl.obolibrary.org/obo/MONDO_0020201) (conjunctival telangiectasia (disease)), [MONDO:0008841](http://purl.obolibrary.org/obo/MONDO_0008841) (ataxia-telangiectasia with generalized skin pigmentation and early death), [MONDO:0008501](http://purl.obolibrary.org/obo/MONDO_0008501) (Sturge-Weber syndrome), [MONDO:0020202](http://purl.obolibrary.org/obo/MONDO_0020202) (conjunctival lymphangiectasia), [MONDO:0009535](http://purl.obolibrary.org/obo/MONDO_0009535) (lymphedema, congenital recessive), [MONDO:0014393](http://purl.obolibrary.org/obo/MONDO_0014393) (lymphedema, hereditary, 1D), [MONDO:0008535](http://purl.obolibrary.org/obo/MONDO_0008535) (telangiectasia, hereditary hemorrhagic, of Rendu, Osler, and Weber), [MONDO:0019180](http://purl.obolibrary.org/obo/MONDO_0019180) (hereditary hemorrhagic telangiectasia), [MONDO:0007920](http://purl.obolibrary.org/obo/MONDO_0007920) (Meige disease), [MONDO:0012765](http://purl.obolibrary.org/obo/MONDO_0012765) (LMPH1B), [MONDO:0012532](http://purl.obolibrary.org/obo/MONDO_0012532) (HHT4), [MONDO:0010996](http://purl.obolibrary.org/obo/MONDO_0010996) (HHT3), [MONDO:0014217](http://purl.obolibrary.org/obo/MONDO_0014217) (telangiectasia, hereditary hemorrhagic, type 5), 

**Corr. equiv. classes:** [OMIM:185300](http://purl.obolibrary.org/obo/OMIM_185300), [Orphanet:100](http://www.orpha.net/ORDO/Orphanet_100), [OMIM:601101](http://purl.obolibrary.org/obo/OMIM_601101), [OMIM:187300](http://purl.obolibrary.org/obo/OMIM_187300), [OMIM:600376](http://purl.obolibrary.org/obo/OMIM_600376), [OMIM:153100](http://purl.obolibrary.org/obo/OMIM_153100), [OMIM:153200](http://purl.obolibrary.org/obo/OMIM_153200), [OMIM:247440](http://purl.obolibrary.org/obo/OMIM_247440), [OMIM:613480](http://purl.obolibrary.org/obo/OMIM_613480), [Orphanet:3205](http://www.orpha.net/ORDO/Orphanet_3205), [OMIM:208910](http://purl.obolibrary.org/obo/OMIM_208910), [OMIM:208900](http://purl.obolibrary.org/obo/OMIM_208900), [Orphanet:98612](http://www.orpha.net/ORDO/Orphanet_98612), [OMIM:610655](http://purl.obolibrary.org/obo/OMIM_610655), [Orphanet:98613](http://www.orpha.net/ORDO/Orphanet_98613), [OMIM:611944](http://purl.obolibrary.org/obo/OMIM_611944), [Orphanet:98614](http://www.orpha.net/ORDO/Orphanet_98614), [Orphanet:79452](http://www.orpha.net/ORDO/Orphanet_79452), [OMIM:615506](http://purl.obolibrary.org/obo/OMIM_615506), [Orphanet:90186](http://www.orpha.net/ORDO/Orphanet_90186), [OMIM:615907](http://purl.obolibrary.org/obo/OMIM_615907), [Orphanet:774](http://www.orpha.net/ORDO/Orphanet_774), 

**Class expressions from DL-Learner:**

- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) and [HP:0012443](http://purl.obolibrary.org/obo/HP_0012443) (Abnormality of brain morphology) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0002011](http://purl.obolibrary.org/obo/HP_0002011) (Morphological abnormality of the central nervous system) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) and [HP:0002086](http://purl.obolibrary.org/obo/HP_0002086) (Abnormality of the respiratory system) 59.93%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0001871](http://purl.obolibrary.org/obo/HP_0001871) (Abnormality of blood and blood-forming tissues) 57.74%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) 48.98%
- [HP:0000524](http://purl.obolibrary.org/obo/HP_0000524) (Conjunctival telangiectasia) and [HP:0000707](http://purl.obolibrary.org/obo/HP_0000707) (Abnormality of the nervous system) 48.98%
- [HP:0008054](http://purl.obolibrary.org/obo/HP_0008054) (Abnormality of the vasculature of the conjunctiva) 46.26%
- [HP:0000118](http://purl.obolibrary.org/obo/HP_0000118) (Phenotypic abnormality) 38.40%
- Thing 38.39%
- [HP:0000001](http://purl.obolibrary.org/obo/HP_0000001) (All) 38.39%
- [HP:0001626](http://purl.obolibrary.org/obo/HP_0001626) (Abnormality of the cardiovascular system) 32.98%


